Medicare utilization — DANIELLE NORRIS (ARNP)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 700 | 12 | $0 | $23,931 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 274 | 179 | $0 | $21,502 |
| 36415 | Insertion of needle into vein for collection of blood sample | 160 | 132 | $0 | $1,336 |
| 85610 | Blood test, clotting time | 140 | 92 | $0 | $584 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 67 | 67 | $0 | $8,133 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·